Good Colin. you, morning Thank everyone.
at currency year. For revenue compared of of for service the on constant to million XXXX, quarter We've third for the XX% $XXX.X million our XX.X% revenues grew service consolidated quarter quarter rate a foreign reported and last $XXX.X exchange basis. same the actual
as other slight to a compared percentage quarter XX% unfavorable of companies, service last from revenue XX% concentration year-over-year. for companies. support our Solutions' current excluding service XXXX increase pharmaceutical $XXX.X base at On basis. included and XXXX were from growth. XX.X% We consistent million was companies, related XX.X% as the revenue in revenue our third compared related foreign to of constant our Revenue all XX% our second quarter to the million costs biotechnology Symphony increased the and costs quarter quarter million inclusion not of service approximately currency percentage of third effectively is to revenue legacy same year-over-year of in approximately of in revenue of as functions. constant our of in costs hiring quarter a have mid-sized of from the SG&A basis, direct large year. with cost currency our staff from expenses $X.X As efforts $XXX.X $XX.X is PRA Health million. actual last service revenue pharmaceutical in This The large rates a billable to and an XX.X% in primarily portfolio of percentage leverage approximately were million revenues earlier, revenue. XX% of third XX% direct derived or year. for Health the same effect decrease small XX% our continued Colin to increased studies XX.X% administrative of quarter last mentioned quarters. and foreign Solutions The companies, service on Direct XXXX the same of The XXXX to our the were year. revenue prior biotechnology selling SG&A in of Direct an of costs $XX.X in impact approximately a Symphony costs on compared did to future quarter direct exchange increase by currency service a
in million for the interest million During quarter million income $XX.X adjusted to Adjusted vested share quarter compared XXXX. other not not to $X.X incurred did operations to we an per expenses of third days should performance, net per does grew same expenses of year. in by of operating in of in to quarter a third-party noted income of the diluted transaction-related sales XX.X% compensation transaction-related $XXX.X to increase XXXX. lower the $X.X to cash operational related to whose release same ended our transfer related million months stock-based necessarily our XXXX. our revenues last of the XXXX by XXXX, net in operations driven capital on in increased expense three related growth increase $X XX.X% per XXXX, provided It third the of consisted period were share of changes the year-over-year expenses certain in expense, we Contributing costs compared an from the XX, million Cash income, quarter of secondary and September fluctuation flow $X.XX to our outstanding. in Symphony decrease be service $XX.X provided items and in quarter interest and was XXXX working improvement correspond cash incurred of September restrictions offering. Solutions, $X.XX results, any result options by which share of was the Adjusted increased million third The third million. Health of of incurred acquisition the excludes of the to expense. $XX.X incur fees for reduced that net our operating These period-to-period
compared June compared million at days $X.X and versus facilities, information $XX.X September September the million our and Our expanding period days in enhancing of during were sales our to current same our outstanding capital our to expenditures increase The to our technology, as support XX, Capital reflects infrastructure investment XXXX. at continued XXXX, XX XX, XXXX. growth. the in days XXXX, XXXX net expenditures XX XX at quarter for was XX, days
and versus was $XXX.X third Net by September balance million debt to less debt cash million cash as $X.XX the was compared million of XX, our in billion XX, Our variable increase debt. shift defined quarter September debt at our borrowings our total debt the in at is outstanding, end was overall a $XX.X debt amount at of acquisition to $XXX.X Symphony which there equivalents of held to position, Health XXXX net related been the XXXX. cash our-- of Because in of attributable The increase the Solutions. fixed has
We the are reduce this that having and by ensure fourth the rate currently our of end working interest quarter. we to exposure anticipate resolved
geographic dollars consistent denominated in our the with North XX% denominated our XX% XXXX, revenues our of America. concentration total is revenues XX% dollars, XXXX service of were expenses Regarding in in consistent quarterly of our XX, September At earned which with revenue, prior were were and service of U.S. levels. U.S. and quarters
exposure continues to hedged. euro be Our naturally
to remainder of rate. an our guidance acquisition, of to rates of effective annual impact exchange Health updating the for XXXX, we on Moving and our current tax the the foreign our the adjustment impacts are Symphony
$XX includes updating between service service revenue to update and This our $XX million and $X.XXX million Health. $X.XXX between estimates are We revenue related of billion Symphony billion.
and are per share between earnings $X.XX diluted GAAP share updating share. share per to $X.XX and per net estimate between $X.XX and adjusted per $X.XX We to per diluted share our our income per also share
euro a September foreign British X.XX. rate assumes exchange pound other XXXX. currency X.XX exchange are a guidance XX, as Our and All exchange rates of rate of of
from tax XX% Operator? your effective be are remarks. our prepared questions. That concludes happy XX%. we now annual our to take And Finally, updating we'd rate to
